A key priority for PVR-Inox is improving margins through better capital and operating expenses, says MD Ajay Bijli. In an interview with Vinod Mahanta and Javed Farooqui, Bijli talks about the contours of the deal to merge the two firms that has created the world’s fifth-largest multiplex chain, and the way ahead. Edited excerpts:
Symbiotec Pharmalab sets price band for Rs 1,757 crore IPO, to open on August 24
Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 15 shares,